Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.20 | -$0.20 | -$0.20 |
Q2 2025 | 1 | -$0.21 | -$0.21 | -$0.21 |
Q3 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
Q4 2025 | 1 | -$0.26 | -$0.26 | -$0.26 |
Q1 2026 | 1 | -$0.08 | -$0.08 | -$0.08 |
Q2 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
Q3 2026 | 1 | -$0.15 | -$0.15 | -$0.15 |
Q4 2026 | 1 | -$0.18 | -$0.18 | -$0.18 |
InspireMD, Inc. last posted its earnings results on Wednesday, March 12th, 2025. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.2 by $0.01. The company had revenue of 1.95 M for the quarter and had revenue of 7.01 M for the year. InspireMD, Inc. has generated $-1 earnings per share over the last year ($-0.76 diluted earnings per share) and currently has a price-to-earnings ratio of -3.94. InspireMD, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
03/12/2025 | Q4 2024 | -$0.20 | $0.01 | 0.21 | $1.82 M | $1.95 M |
11/12/2024 | Q3 2024 | -$0.20 | -$0.16 | 0.04 | $1.74 M | $1.81 M |
08/05/2024 | Q2 2024 | N/A | -$0.22 | N/A | $1.74 M | $1.74 M |
05/13/2024 | Q1 2024 | N/A | -$0.21 | N/A | $2.00 M | $1.51 M |
03/05/2024 | Q4 2023 | N/A | -$0.25 | N/A | $1.63 M | $1.76 M |
11/06/2023 | Q3 2023 | -$0.17 | -$0.15 | 0.02 | $1.50 M | $1.56 M |
08/07/2023 | Q2 2023 | N/A | -$0.24 | N/A | $1.55 M | $1.65 M |
05/15/2023 | Q1 2023 | -$0.68 | -$0.53 | 0.15 | N/A | $1.24 M |
03/30/2023 | Q4 2022 | $0.84 | -$0.60 | -1.44 | N/A | $1.03 M |
11/07/2022 | Q3 2022 | N/A | -$0.58 | N/A | $1.40 M | $1.43 M |
08/08/2022 | Q2 2022 | N/A | -$0.59 | N/A | $1.20 M | $1.53 M |
05/09/2022 | Q1 2022 | N/A | -$0.57 | N/A | N/A | $1.18 M |
03/07/2022 | Q4 2021 | N/A | -$0.53 | N/A | N/A | $1.38 M |
11/08/2021 | Q3 2021 | N/A | -$0.53 | N/A | $1.20 M | $1.07 M |
08/09/2021 | Q2 2021 | N/A | -$0.46 | N/A | $1.10 M | $1.04 M |
05/10/2021 | Q1 2021 | N/A | -$0.53 | N/A | N/A | $1.01 M |
03/08/2021 | Q4 2020 | N/A | -$1.52 | N/A | N/A | $158,000 |
11/09/2020 | Q3 2020 | -$4.20 | -$0.96 | 3.24 | $600,000 | $980,000 |
08/05/2020 | Q2 2020 | -$5.25 | -$2.93 | 2.32 | $200,000 | $313,000 |
05/11/2020 | Q1 2020 | N/A | -$6.42 | N/A | N/A | $1.03 M |
InspireMD, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 12th, 2025 based offlast year's report dates.
In the previous quarter, InspireMD, Inc. (:NSPR) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.2 by $0.01.
The conference call for InspireMD, Inc.'s latest earnings report can be listened to online.
The conference call transcript for InspireMD, Inc.'s latest earnings report can be read online.
InspireMD, Inc. (:NSPR) has a recorded annual revenue of $7.01 M.
InspireMD, Inc. (:NSPR) has a recorded net income of $1.56 M.InspireMD, Inc. has generated $-0.76 earnings per share over the last four quarters.
InspireMD, Inc. (:NSPR) has a price-to-earnings ratio of -3.94 and price/earnings-to-growth ratio is -0.13.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED